Advertisement

Current Guidelines and Recommendations for Thrombolysis Use in Pulmonary Embolism

  • Carlos Jerjes-SánchezEmail author

Abstract

Currently, guidelines and recommendations are important tools to help physicians related with acute pulmonary embolism patient care to weigh the benefits and risks of anticoagulation and specifically, thrombolytic agents use. Guidelines and recommendations should be helpful in every day clinical decision-making to improve acute patient care. In the last years, the European Society of Cardiology, the American Heart Association, and the American College of Chest Physicians brought together leading experts in pulmonary embolism, stratification, diagnosis, and treatment. This chapter will be focusing on the guidelines and recommendations on pulmonary embolism and thrombolysis coming from the most important cardiology societies and experts in America and Europe. A brief overview on methodology and recommendations level, as well as, evidence level will be present. In addition, a fast-track analysis comparing thrombolytic regimens in terms of efficacy and safety will be available. Although, all of these guidelines and recommendations are available online, in this chapter the readers will have a quick and easy access.

Keywords

Guidelines Recommendations Pulmonary embolism Thrombolysis Fibrinolytic therapy 

References

  1. 1.
    Konstantinides SV, Torbicki A, Agnelli G, Danchin N, Fitzmaurice D, Galie N, Gibbs JSR, Huisman MV, Humbert M, Kucher N, Lang I, Lankeit M, Lekakis J, Maack C, Mayer E, Meneveau N, Perrier A, Pruszczyk P, Rasmussen LH, Schindler TH, Svitil P, Noordegraaf AV, Zamorano JL, Zompatori M. 2014 ESC guidelines on the diagnosis and management of acute pulmonary embolism. The Task Force for the Diagnosis and Management of Acute Pulmonary Embolism of the European Society of Cardiology (ESC). Eur Heart J. 2014;35:3033–80. doi: 10.1093/eurheartj/ehu283.CrossRefPubMedGoogle Scholar
  2. 2.
    Jaff MR, McMurtry MS, Archer SL, Cushman M, Goldenberg NA, Goldhaber SZ, Jenkins JS, Kline JA, Michaels AD, Thistlethwaite P, Vedantham S, White RJ, Zierler BK, on behalf of the American Heart Association Council on Cardiopulmonary, Critical Care, Perioperative and Resuscitation, Council on Peripheral Vascular Disease, and Council on Arteriosclerosis, Thrombosis and Vascular Biology. Management of massive and submassive pulmonary embolism, iliofemoral deep vein thrombosis, and chronic thromboembolic pulmonary hypertension: a scientific statement from the American Heart Association. Circulation. 2011;123:1788–830. doi: 10.1161/CIR.0b013e318214914f.CrossRefPubMedGoogle Scholar
  3. 3.
    Kearon C, Akl EA, Comerota AJ, Prandoni P, Bounameaux H, Goldhaber SZ, Nelson ME, Wells PS, Gould MK, Dentali F, Crowther M, Kahn SR. Antithrombotic therapy for VTE disease: antithrombotic therapy and prevention of thrombosis, 9th ed: American College of Chest Physicians evidence-based clinical practice guidelines. Chest. 2012;141(2 Suppl):e419S–94S.PubMedCentralPubMedGoogle Scholar
  4. 4.
    Wan S, Quinlan DJ, Agnelli G, Eikelboom JW. Thrombolysis compared with heparin for the initial treatment of pulmonary embolism: a metaanalysis of the randomized controlled trials. Circulation. 2004;110:744–9.CrossRefPubMedGoogle Scholar
  5. 5.
    Thabut G, Thabut D, Myers RP, Bernard-Chabert B, Marrash-Chahla R, Mal H, Fournier M. Thrombolytic therapy of pulmonary embolism: a meta-analysis. J Am Coll Cardiol. 2002;40:1660–7.CrossRefPubMedGoogle Scholar
  6. 6.
    Kasper W, Konstantinides S, Geibel A, Olschewski M, Heinrich F, Grosser KD, Rauber K, Iversen S, Redecker M, Kienast J. Management strategies and determinants of outcome in acute major pulmonary embolism: results of a multicenter registry. J Am Coll Cardiol. 1997;30:1165–71.CrossRefPubMedGoogle Scholar
  7. 7.
    Goldhaber SZ, Visani L, De Rosa M. Acute pulmonary embolism: clinical outcomes in the International Cooperative Pulmonary Embolism Registry (ICOPER). Lancet. 1999;353:1386–9.CrossRefPubMedGoogle Scholar
  8. 8.
    Laporte S, Mismetti P, Décousus H, Uresandi F, Otero R, Lobo JL, Monreal M, RIETE Investigators. Clinical predictors for fatal pulmonary embolism in 15,520 patients with venous thromboembolism: findings from the Registro Informatizado de la Enfermedad Trombo-Embolica venosa (RIETE) Registry. Circulation. 2008;117:1711–6.CrossRefPubMedGoogle Scholar
  9. 9.
    Schreiber D, Lin B, Liu G, Briese B, Hiestand B, Slatter D, Kline J, Pollack C. Variation in therapy and outcomes in massive pulmonary embolism from the Emergency Medicine Pulmonary Embolism in the Real World Registry (EMPEROR). Acad Emerg Med. 2009; 16(S77).Google Scholar
  10. 10.
    De Soyza ND, Murphy ML. Persistent post-embolic pulmonary hypertension. Chest. 1972;62:665–8.CrossRefPubMedGoogle Scholar
  11. 11.
    Schwarz F, Stehr H, Zimmermann R, Manthey J, Kübler W. Sustained improvement of pulmonary hemodynamics in patients at rest and during exercise after thrombolytic treatment of massive pulmonary embolism. Circulation. 1985;71:117–23.CrossRefPubMedGoogle Scholar
  12. 12.
    Sharma GV, Folland ED, McIntyre KM, Sasahara AA. Long-term benefit of thrombolytic therapy in patients with pulmonary embolism. Vasc Med. 2000;5:91–5.CrossRefPubMedGoogle Scholar
  13. 13.
    Kline JA, Steuerwald MT, Marchick MR, Hernandez-Nino J, Rose GA. Prospective evaluation of right ventricular function and functional status 6 months after acute submassive pulmonary embolism: frequency of persistent or subsequent elevation in estimated pulmonary artery pressure. Chest. 2009;136:1202–10.PubMedCentralCrossRefPubMedGoogle Scholar
  14. 14.
    Meyer G, Vicaut E, Danays T, Agnelli G, Becattini C, Beyer-Westendorf J, Bluhmki E, Bouvaist H, Brenner B, Couturaud F, Dellas C, Empen K, Granca A, Galiè N, Geibel A, Goldhaber SZ, Jimenez D, Kozak M, Kupatt C, Kucher N, Lang IM, Lankeit M, Meneveau N, Pacouret G, Palazzini M, Petris A, Pruszczyk P, Rugolotto M, Salvi A, Schellong S, Sebbane M, Sobkowicz B, Stefanovic BS, Thiele H, Torbicki A, Verschuren F, Konstantinides SV, PEITHO Investigators. Fibrinolysis for patients with intermediate-risk pulmonary embolism. N Engl J Med. 2014;370:1402–11.CrossRefPubMedGoogle Scholar
  15. 15.
    Kline JA, Nordenholz KE, Courtney DM, Kabrhel C, Jones AE, Rondina MT, Diercks DB, Klinger JR, Hernandez J. Treatment of submassive pulmonary embolism with tenecteplase or placebo: cardiopulmonary outcomes at 3 months: multicenter double-blind, placebo-controlled randomized trial. J Thromb Haemost. 2014;12:459–68.CrossRefPubMedGoogle Scholar
  16. 16.
    Guyatt GH, Norris SL, Schulman S, Hirsh J, Eckman MH, Akl EA, Crowther M, Vandvik PO, Eikelboom JW, McDonagh MS, Lewis ZS, Gutterman DD, Cook DJ, Schünemann HJ. Methodology for the development of antithrombotic therapy and prevention of thrombosis guidelines antithrombotic therapy and prevention of thrombosis, 9th ed: American College of Chest Physicians Evidence-Based Clinical Practice Guidelines. Chest. 2012;141(2 Suppl):e53S–70S.CrossRefGoogle Scholar

Copyright information

© Springer International Publishing Switzerland 2015

Authors and Affiliations

  1. 1.Instituto de Cardiologia y Medicina Vascular, TEC SaludSan Pedro Garza GarciaMexico
  2. 2.Escuela de Medicina, Tecnológico de MonterreySan Pedro Garza GarciaMexico
  3. 3.Unidad de Investigacion Clinica en Medicina SCMonterreyMexico

Personalised recommendations